Global Life Science Services Platform Unites Under New Name, EVERSANA

Our industry is constantly evolving. So it’s time for change in the services business too. Anchored to the Latin word “sana” for healthy and “ever” for continual evolution, EVERSANA™ now offers a comprehensive platform of integrated services to help innovators and established pharmaceutical companies navigate the era of patient-centered, value-based care.          

The journey began when Water Street Healthcare Partners and JLL Partners  joined forces to acquire and combine the most comprehensive platform of life sciences services in the industry. EVERSANA encompasses six premier service providers that Water Street and JLL Partners merged over the past year to form the industry-leading platform, including Dohmen Life Science Services, The Access Group, Alliance Life Sciences, Health Strategies Group, Triplefin, and Patient Experience Project. Together as EVERSANA, the organization delivers a fully-integrated service portfolio to help life science leaders create value for key constituents across the product lifecycle.

 “As our name implies, EVERSANA is poised to offer the services and products that support today’s needs and tomorrow’s future,” said Jim Lang, Chief Executive Officer, EVERSANA. “Together, we offer integrated solutions to the life science industry that address the shift to value-based, patient-centered care and deliver long-term sustainable value for payers, providers, channel partners, and patients.”

EVERSANA offers the largest service array for critical rare, orphan, and complex specialty therapies. Its portfolio includes management and regulatory strategy, marketing agencies, outsourced distribution, patient engagement and support, pharamacovigilance, medical communication, and safety, as well as research, global pricing software and analytics. From start-ups to established global pharmaceutical leaders – EVERSANA offers more than 500 clients – the services they need to bring critical therapies to market while improving the lives of patients around the world.

“We’ve bridged the gap between science and sales to bring forward-looking commercial thinking to the world of innovation, as well as scientific excellence throughout the product lifecycle,” added Lang.

Fueled by a vision to advance life science services toward a healthier world, we put equal weight on how we partner with our clients to improve the lives of patients. How we operate is grounded in our cultural beliefs – shared by more than 1,500 experts and professionals around the world that collaborate with our clients to maximize the impact of new therapies.

The company’s new logo features images of building blocks to represent its key service areas that surround a central point to reinforce a focus on the patient, and a flower to represent the growth of a new model to support healthier outcomes.

To learn more about EVERSANA visit